A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors
about
Foamy virus vectors for HIV gene therapyFoamy virus budding and releaseA novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cellsA unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsidEleventh International Foamy Virus Conference-Meeting ReportAn N-terminal domain helical motif of Prototype Foamy Virus Gag with dual functions essential for particle egress and viral infectivityDifferential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particlesThe cooperative function of arginine residues in the Prototype Foamy Virus Gag C-terminus mediates viral and cellular RNA encapsidation.In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma.Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transferAdvances in foamy virus vector technology and disease correction could speed the path to clinical applicationInteractions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.Structure of a Spumaretrovirus Gag Central Domain Reveals an Ancient Retroviral Capsid.In Vitro Evolution of Bovine Foamy Virus Variants with Enhanced Cell-Free Virus Titers and Transmission.Feline foamy virus-based vectors: advantages of an authentic animal model.Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry.Characterization and manipulation of foamy virus membrane interactions.
P2860
Q26859020-34A18665-E878-458A-B8BA-2C03986F7AB0Q27015997-391A4EA1-4215-46E3-ACBC-61885E7576BFQ27345360-BCC1C36C-8882-43B0-BBCF-EDE0C574696EQ27678148-027357AC-5BAE-4BD9-923D-DE760518A2E8Q28591842-6E6E6F31-7852-4251-98E6-70895460874BQ28685457-C798B5BD-55DE-4915-A801-F3CCC58D8DFDQ30528266-8EB2FAE3-A79B-43C1-9A43-C6116C3F01DCQ34346367-5A640BF5-8CBB-4453-998F-6B2BD720029AQ34636519-1B0720A4-8AC9-4B8C-8037-65A05E4ABFF0Q35618845-58AB4AB0-6CD1-431D-831D-B3D1FB9A49FAQ36014053-D19B621B-AC60-4441-B94C-F084D3935F3EQ36118484-183B63D9-DB5F-4A71-8E7D-358095A80A69Q36187632-903D65D8-C5A8-4D56-9911-B6EF8D9EDEA2Q36333631-B78638A5-42E1-4E25-A34D-C868689C1194Q38121801-0ECC72DB-328E-4632-812D-FF5D00269503Q39217498-3FFA22EE-A6BA-4060-AC8B-7771D92C7B56Q45354422-7DD21B89-6D6F-42ED-97CD-75CCA7F6F247
P2860
A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A small-molecule-controlled sy ...... prototype foamy virus vectors
@en
A small-molecule-controlled sy ...... prototype foamy virus vectors.
@nl
type
label
A small-molecule-controlled sy ...... prototype foamy virus vectors
@en
A small-molecule-controlled sy ...... prototype foamy virus vectors.
@nl
prefLabel
A small-molecule-controlled sy ...... prototype foamy virus vectors
@en
A small-molecule-controlled sy ...... prototype foamy virus vectors.
@nl
P2093
P2860
P356
P1433
P1476
A small-molecule-controlled sy ...... prototype foamy virus vectors
@en
P2093
Anka Swiersy
Kristin Stirnnagel
Viktor Schnabel
Yu-Ping Ho
P2860
P304
P356
10.1038/MT.2012.61
P577
2012-04-03T00:00:00Z